Recent evidence suggests that CTL recognize the peptide degradation products of viral proteins presented at the surface of infected cells in association with class I molecules of the MHC (1-12). However, the mechanisms by which peptide epitopes are generated and transported to the cell surface in vivo are not known.
Recent evidence suggests that CTL recognize the peptide degradation products of viral proteins presented at the surface of infected cells in association with class I molecules of the MHC (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . However, the mechanisms by which peptide epitopes are generated and transported to the cell surface in vivo are not known.
There are two models that could explain the mechanism ofpresentation ofa viral peptide epitope at the cell surface. Viral proteins may be degraded by proteases in the cytoplasm to form short peptide epitopes . These peptides would then have to contain all the necessary information to cross a bilipid membrane in order to reach the cell surface (1, 2) . Alternatively, larger protein fragments may be transported across a bilipid membrane before degradation, in which case signals for transport could be encoded separately to those forming the minimal epitope.
In previous work (1, 13) we have shown that presentation of epitopes does not depend on a single identifiable signal sequence in either the influenza nucleoprotein (NP) or haemagglutinin (HA) . However, these experiments involved expression of protein fragments >130 amino acids long, and could not rule out a role for amino acid sequences outside the minimal epitopes defined with synthetic peptides . A recent report (14) describes recognition by CTL of cells that synthesize a hydrophobic fragment of 41 amino acids derived from the transmembrane region of influenza HA. However, this fragment is also longer than the minimal epitope contained within it (6) .
To try and resolve this issue, we have constructed a recombinant vaccinia virus designed to express a minimal peptide epitope consisting of 15 amino acids of the influenza NP in the cytoplasm of infected cells. We report here that target cells infected with this recombinant vaccinia virus are recognized efficiently by class I-restricted CTL, suggesting that transport of the epitope to the cell surface requires no additional sequence information. This observation is consistent with the first suggested model and implies that a peptide transport system exists in eukaryotic cells.
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Materials and Methods
Construction of 366-379-NP-VAC 75K. Two oligonucleotides 66 bases long were synthesized on a DNA synthesizer (381A; Applied Biosystems, Inc., Foster City, CA). They were designed so that when annealed they would consist of a sequence that would ligate to a Hind III site, the initiator methionine codon together with the preceding nine nucleotides of untranslated sequence of the influenza A/NT/60/68 NP gene (15) , and the codons for amino acids 366-379 of NP, followed by two stop codons and a sequence that would ligate to Bam HI site . The sequences of the oligonucleotides were : (5')-AGCTTATCAAAATCATGGCTT CAAATGAAAACATGGATGCTATGGAATCAAGTACTCTTTGATAAG-(3') and (5')-GAT CCTTATCAAAGAGTACTTGATTCCATAGCATCCATGTTTTCATTTGAAGCCATG-ATTTTGATA-(3') . They encode the amino acid sequence met-ala-ser-asn-glu-asn-met-aspala-met-glu-ser-ser-thr-leu. The gel-purified oligonucleotides were annealed and ligated into Hind III and Bam HI cut pKG18 downstream of the 7.5-kD vaccinia promoter, which is active during both early and late phases of infection (16) . pKG18 was derived from pGS62 (16) and contains extra cloning sites for expression (K. Gould; unpublished results) . After the ligation, the construct was checked by DNA sequencing.
Production of recombinant vaccinia virus by insertion into the tk gene followed standard procedures (16) . Recombinants were identified by hybridization with one of the 12 P-labeled oligonucleotides described above, and plaque purified twice. The vaccinia expressing residues 366-379 from influenza A/NT/60/68 NP will be referred to as 366-379-NP-VAC 7.5K.
A control vaccinia expressing a rapidly degraded form of the full-length influenza A/NT/60/68 NP fused to murine ubiquitin (Ub-Arg-NP-VAC 7.5K) has been described (17) . We have previously shown that L/Db cells infected with this virus are recognized by class I-restricted CTL from CBA (H2-k) and C57BL (H2-b) mice as efficiently as influenza-infected cells (17) .
CTL Cultures, Clones, and Rptides. Clone F5 is specific for the sequence 366-379 derived from the NP of influenza A/NT/60/68 in association with H-2D b and has been described previously (2) . Polyclonal CTL derived from CBA mice and specific for the amino acid sequence 50-63 derived from the NP of A/NT/60/68 in association with H-2Kk were induced in influenza-infected mice as described previously (5) . Peptides were synthesized by solid phase techniques on a synthesizer (430A; Applied Biosystems, Inc.) as described (2) and were kindly supplied by Jonathan Rothbard (Imperial Cancer Research Fund, London, UK).
Cytotoxic Assay. A standard 6-h "Cr release assay was used as previously described using either L cells transfected with the class I gene H-2D 6 (18), or untransfected L cells. 2-5 x 10 6 target cells were infected with 10 plaque-forming units (PFU) per cell of recombinant vaccinia and labeled with 5'Cr for 90 min. After being washed twice, the cells were resuspended at 106 cell/ml in RPMI/10% FCS for 4 h at 37oC, washed twice, and used in the assay. In experiments with cycloheximide, target cells were resuspended in RPMI/10% FCS containing 2 x 10 -4 M cycloheximide for 30 min before infection with vaccinia virus. All subsequent manipulation of the cells (including the washes) were as above but included cycloheximide at the same concentration. In experiments where peptides were included in the assay, these were present throughout the period of contact between CTL and target cells as described (2), at a final concentration of 2 x 10 -5 M. Percent specific chromium release was calculated as : 100 x (release by CTL -medium release)/(2 .5% Triton release -medium release) . All points were measured in duplicate against quadruplicate controls. Spontaneous stricted, as F5 failed to recognize infected L cells that did not express Db (Fig. 1  b) . Fig. 1 c demonstrates that recognition of 366-379-NP-VAC 7.5K-infected cells was antigen specific, because a polyclonal CTL line derived from CBA (H-2k) mice specific for the NP sequence 50-63 (5) did not lyse 366-379-NP-VAC 7 .5K-infected L cells. The polyclonal CTL line did lyse L cells infected with Ub-arg-NP-VAC 7.5K that expressed the complete molecule containing the epitope defined with peptide 50-63 (Fig. 1 c) .
To show that clone F5 recognized the peptide sythesized in infected target cells, and not free peptide contaminating the recombinant vaccinia preparation, cycloheximide was used to inhibit protein synthesis in the 366-379-NP-VAC 7.5K-infected L/Db cells. Fig. 1 d shows that presentation of the epitope 366-379 in recombinant vaccinia-infected cells to clone F5 was completely inhibited by 2 x 10 -4 M cycloheximide . In contrast, Fig. 1 e shows that an identical treatment of target cells with cycloheximide had no significant effect on presentation by L/Db of externally added peptide. These results are consistent with newly synthesized peptide being recognized by clone F5 at the surface of 366-379-NP-VAC 7.5K-infected target cells.
To show that recognition by clone F5 was not due to release of peptide from cells damaged by vaccinia infection, we did a mixing experiment . Equal numbers of uninfected "Cr-labeled L/Db cells and unlabeled 366-379-NP-VAC 7.5K-infected L/Db cells were mixed and incubated with clone F5 . We could find no evidence for transfer of peptide between target cells (Fig . 2) . The "Cr release assay was done as described in Materials and Methods . All points were measured in quadruplicate.
Discussion
We have previously shown that target cells synthesizing deletion mutants of both influenza NP and HA that lacked hydrophobic signal sequences were recognized efficiently by CTL, implying that signal-dependent transport across the membrane of the rough endoplasmic reticulum did not play a role in presentation of epitopes to class I-restricted CTL (1, 13) . This was particularly clear for HA, as deletion of the N112-terminal signal sequence actually enhanced presentation of epitopes to CTI, in recombinant vaccinia-infected target cells, while preventing transport of the molecule into the endoplasmic reticulum, as determined by the lack of detectable glycosylation of nascent signal-deleted HA chains (17) .
We extend these results by showing that a minimal peptide epitope, synthesized by recombinant vaccinia virus in infected cells, is presented to class I-restricted CTL. Although there is no direct evidence that only a 15-amino acid peptide of NP is synthesized in the infected cells, the expression construct contains two sequential termination codons in frame with the epitope sequence . If alternative translational initiation sites were used, either even shorter NP peptides or sequences unrelated to NP would be made. Neither of these would be recognized by clone F5 (2) .
Vaccinia virus carries out its entire life cycle in the cytoplasm of infected cells, so that the NP peptide should be synthesized in the cytosol. This implies that the NP epitope, consisting of residues 366-379, contains sufficient information to be transported from the cytoplasm to the cell surface. It is conceivable that vacciniaencoded proteins may have some effect in assisting transport, although vaccinia infection tends to inhibit rather than assist presentation of epitopes to class I-restricted CTL (19) .
An additional point of interest is that the inhibitory effect of vaccinia infection on presentation of the NP epitope 366-379 in cells expressing the full-length molecule (17) is overcome by expressing the epitope as a peptide. This is consistent with the vaccinia inhibitory effect acting at a point before transport and association of the epitope with class I molecules, and would be explained by specific inhibition of proteolysis .
Our results are consistent with a previously proposed hypothesis that large protein antigens are degraded in the cytoplasm to short peptides, which at least in the case of the epitope studied here, contain sufficient information to allow passage across the bilipid membrane (1, 2) . We can only speculate on the nature of the peptide transport mechanism. It is likely to be constitutive as it must be active in uninfected cells expressing transfected viral genes (18, 20, 21) . It must also have a broad specificity in order to transport peptides of widely differing sequence (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . It is noteworthy that the sequence 366-379 of NP contains nine charged or polar residues and is hydrophilic. 
